Niklas Schultz
- Oncology top 0.5%
- PARP inhibition in cancer therapy 11
- Molecular Biology top 1%
- DNA Repair Mechanisms 19
- Molecular Biology Techniques and Applications 4
- Cancer therapeutics and mechanisms 4
- CRISPR and Genetic Engineering 4
- Cancer Research top 2%
- Carcinogens and Genotoxicity Assessment 8
- Reproductive Medicine top 2%
- Genetics top 2%
-
- Microtubule and mitosis dynamics 4
-
- Prostate Cancer Diagnosis and Treatment 4
- Co-authors
- Thomas HelledayHelen E. BryantMark MeuthElena López‐KnowlesSuzanne KyleHuw D. ThomasNicola J. CurtinNatalia Issaeva
- Partner nations
- SwedenUnited KingdomSpain
In The Last Decade
Niklas Schultz
31 papers receiving 6.8k citations
Hit Papers
Peers
Comparison fields: 5 of 117
- Oncology 4.3k
- Molecular Biology 5.5k
- Cancer Research 1.0k
- Reproductive Medicine 339
- Genetics 847
Countries citing papers authored by Niklas Schultz
This map shows the geographic impact of Niklas Schultz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Niklas Schultz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Niklas Schultz more than expected).
Fields of papers citing papers by Niklas Schultz
This network shows the impact of papers produced by Niklas Schultz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Niklas Schultz. The network helps show where Niklas Schultz may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Niklas Schultz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2023 | 33 | |
| 3 | 2022 | 8 | |
| 4 | 2021 | 66 | |
| 5 | 2018 | 343 | |
| 6 | 2015 | 112 | |
| 7 | 2013 | 51 | |
| 8 | 2012 | 18 | |
| 9 | 2012 | 10 | |
| 10 | 2011 | 7 | |
| 11 | 2010 | 59 | |
| 12 | 2010 | 2 | |
| 13 | 2006 | 33 | |
| 14 | Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerasebreakdown → | 2005 | 3780 |
| 15 | 2005 | 140 | |
| 16 | 2004 | 40 | |
| 17 | 2003 | 95 | |
| 18 | 2001 | 4 | |
| 19 | 2000 | 10 | |
| 20 | 1994 | 30 |
About Niklas Schultz
Niklas Schultz is a scholar working on Cancer Research, Oncology and Molecular Biology, having authored 32 papers that have together received 6.9k indexed citations. Recurring topics across this work include DNA Repair Mechanisms (19 papers), PARP inhibition in cancer therapy (11 papers), Carcinogens and Genotoxicity Assessment (8 papers), Molecular Biology Techniques and Applications (4 papers), Microtubule and mitosis dynamics (4 papers), Cancer therapeutics and mechanisms (4 papers), CRISPR and Genetic Engineering (4 papers) and Prostate Cancer Diagnosis and Treatment (4 papers). The work is most often cited by research in Oncology (4.3k citations), Molecular Biology (5.5k citations) and Cancer Research (1.0k citations). Niklas Schultz has collaborated with scholars based in Sweden, United Kingdom and Spain. Frequent co-authors include Thomas Helleday, Helen E. Bryant, Mark Meuth, Elena López‐Knowles, Suzanne Kyle, Huw D. Thomas, Nicola J. Curtin, Natalia Issaeva, Eva Petermann and Manuel Luís Orta. Their work appears in journals such as Nature Communications, Molecular and Cellular Biology, Nature, Journal of Molecular Biology and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.